Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Yield Growth Subsidiary Lab Begins Psilocybin Mushroom R&D

Stockhouse Editorial
1 Comment| January 7, 2020

{{labelSign}}  Favorites
{{errorMessage}}

Yield Growth Corp. (CSE:BOSS, OTCQB:BOSQF, Forum) announced on Tuesday that its subsidiary Flourish Mushroom Labs Inc. will build a laboratory to cultivate psilocybin mushrooms for research and development into therapeutic psychedelic mushroom compounds.

To find out more, click here.

This is another step in BOSS’ ongoing work into psychedilic research, having established a broad distribution network for its various brands, exceeding 12,500 potential retail points of sale in countries throughout Europe, North America and South America. The Company intends to advance relationships to get products on store shelves and in the hands of consumers with the goal to increase sales revenues in the coming quarters in 2020.

FULL DISCLOSURE: Yield Growth Corp. is a client of Stockhouse Publishing.



{{labelSign}}  Favorites
{{errorMessage}}

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today

Featured Company